Spineway SA (EPA:ALSPW)

Market Cap	1.51M
Revenue (ttm)	12.73M
Net Income (ttm)	-3.87M
Shares Out	12.58M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,858
Average Volume	232,782
Open	0.1172
Previous Close	0.1198
Day's Range	0.1170 - 0.1214
52-Week Range	0.0730 - 0.6500
Beta	0.83
RSI	45.38
Earnings Date	Sep 22, 2025

About Spineway

Spineway SA engages in the design, manufacture, and marketing of implants and instruments for the treatment of spinal pain. The company offers posterior fixation, including posterior osteosynthesis systems; veos titanium is a top-loading posterior osteosynthesis system; veos peek-optima image contrast is a top-loading posterior fixation system offering the possibility to perform semi-rigid posterior fixation; kaphorn is a side loading posterior osteosynthesis system; Mont Blanc mis, is a complete implant system for thoraco-lombo-sacral posterio...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2005
• Employees: 49
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALSPW

Financial Performance

In 2024, Spineway's revenue was 12.73 million, an increase of 12.11% compared to the previous year's 11.36 million. Losses were -3.87 million, -40.63% less than in 2023.